XML 33 R19.htm IDEA: XBRL DOCUMENT

Note 11 - Income Taxes	3 Months Ended
Mar. 31, 2021
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 11 — INCOME TAXES The Company’s effective tax rate expense (benefit) for the three months ended March 31, 2021 and 2020 was 14.8% and 37.2%, respectively. The effective rate differs from the federal statutory rate of 21% for the three months ended March 31, 2021 primarily due to the income tax benefit recognized during the first quarter of 2021 related to the reduced Israel tax rate on preferred technological income for tax years 2019 and 2020, partially offset by the mix of business in various countries with higher statutory tax rates than the federal statutory tax rate and new reserves established for unrecognized tax benefits. In response to the COVID-19 pandemic, many governments have enacted or are contemplating measures to provide aid and economic stimulus. The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020 in the United States provides relief on deferral of tax payments and filings, modifies the net operating loss utilization rules, and temporarily increases the interest expense deduction allowed. For the three months ended March 31, 2021, there were no material tax impacts to our consolidated financial statements as it relates to the CARES Act or other COVID-19 stimulus measures. The Company will continue to monitor additional guidance issued by Treasury, the Internal Revenue Service and other taxing authorities.

Note 11 - Income Taxes

3 Months Ended

Mar. 31, 2021

NOTE 11 — INCOME TAXES

The Company’s effective tax rate expense (benefit) for the three months ended March 31, 2021 and 2020 was 14.8% and 37.2%, respectively. The effective rate differs from the federal statutory rate of 21% for the three months ended March 31, 2021 primarily due to the income tax benefit recognized during the first quarter of 2021 related to the reduced Israel tax rate on preferred technological income for tax years 2019 and 2020, partially offset by the mix of business in various countries with higher statutory tax rates than the federal statutory tax rate and new reserves established for unrecognized tax benefits.

In response to the COVID-19 pandemic, many governments have enacted or are contemplating measures to provide aid and economic stimulus. The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020 in the United States provides relief on deferral of tax payments and filings, modifies the net operating loss utilization rules, and temporarily increases the interest expense deduction allowed. For the three months ended March 31, 2021, there were no material tax impacts to our consolidated financial statements as it relates to the CARES Act or other COVID-19 stimulus measures. The Company will continue to monitor additional guidance issued by Treasury, the Internal Revenue Service and other taxing authorities.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details